Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?
Consider This from NPR
NPR
4.2 • 6.2K Ratings
🗓️ 10 September 2020
⏱️ 13 minutes
🧾️ Download transcript
Summary
NPR's Sydney Lupkin reports that the statement comes as a commitment to science, at a time when some Americans have expressed concern that the trials are being rushed.
Part of this concern comes from those who feel politics are influencing the processes vaccines must go through. The Centers for Disease Control and Prevention have told states a potential vaccine may be ready for distribution as soon as late October — right before Election Day. But when speaking with NPR's Mary Louise Kelly, Dr. Moncef Slaoui, chief scientific adviser to Operation Warp Speed, said there is a "very low chance" a vaccine will be ready by then.
While some Americans are skeptical about a coronavirus vaccine, it doesn't seem like many of those people work on Wall Street. Each time a new vaccine trial phase is announced or a new scientific hurdle is cleared, drug company stock goes up. NPR's Tom Dreisbach reported that executives at one company took advantage of those rising stock prices.
Find and support your local public radio station.
Email us at considerthis@npr.org
To manage podcast ad preferences, review the links below:
See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.
Learn more about sponsor message choices: podcastchoices.com/adchoices
NPR Privacy Policy
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Pfizer, Johnson and Johnson and GlaxoSmithCline are some of the biggest drug companies in the world. |
| 0:05.5 | We're talking multi-billion dollar operations. Companies not exactly known for playing nice with |
| 0:10.6 | each other. This morning a major development in the race to produce a coronavirus vaccine and |
| 0:15.9 | something very unprecedented. Some of the country's most well-known drug makers now presenting a |
| 0:21.6 | United Front saying they- This week, nine drug companies, including the ones we just mentioned, |
| 0:26.4 | took the unusual step of banding together to say. With increasing public concerns about the |
| 0:33.2 | processes that we are using to develop these vaccines and even more importantly the processes |
| 0:38.3 | that would be used to evaluate these vaccines, we saw it as critical to come out and |
| 0:43.8 | rein etterate our commitment. That's Pfizer-CEO Albert Borla. That commitment, a pledge not to submit |
| 0:51.4 | a coronavirus vaccine for FDA review unless it's been shown to be safe and effective in large |
| 0:57.2 | clinical trials. And that may sound obvious and also backwards like you'd expect the government |
| 1:04.1 | to be the cautious party here and the drug companies to move fast. But in fact, there's growing |
| 1:09.6 | concern the Trump administration isn't a hurry to get a vaccine out the door before election day. |
| 1:14.7 | So we're going to have a vaccine very soon. Maybe even before a very special day. You know what |
| 1:19.8 | date I'm talking about. Consider this. Hopes for a coronavirus vaccine are high, but trust in the |
| 1:27.1 | process to develop one is less so. From NPR, I'm Audie Cornish. It's Thursday, September 10th. |
| 1:37.9 | Support for this NPR podcast and the following message come from BetterHelp. |
| 1:42.0 | Online counseling by licensed professional counselors specializing in isolation, depression, |
| 1:47.2 | stress and anxiety. Visit BetterHelp.com slash consider to learn more and get 10% off your first month. |
| 1:55.2 | I'm Lisa Hagen. And I'm Chris Axel. We're the hosts of No Compromise. NPR's new podcast |
| 2:01.7 | exploring one family's mission to reconstruct America using two powerful tools, guns and Facebook. |
| 2:08.7 | New episodes drop every Tuesday. Join us for the No Compromise podcast from NPR. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

